Status:
COMPLETED
Moderating the Negative Impact of Abnormal Screening Mammograms
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This project evaluates the impact of CHESS-Mammo by assessing participants' health information competence, psychological distress, and satisfaction with their doctor as measured by previously validate...
Detailed Description
The study consists of two parts. Part 1 (focus groups) interviewed 11 women in total (6 diagnosed with breast cancer and 5 diagnosed with benign breast disease) reinforced the need for online informat...
Eligibility Criteria
Inclusion
- To be eligible for the study, subjects must:
- Be females at least 18 years of age,
- Have had their screening mammogram performed at the UW Breast Center,
- Be able to read and write English at the 6th grade level (as shown by their, ability to understand the informed consent),
- Have access to a computer with internet capability.
Exclusion
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT01153126
Start Date
May 1 2010
End Date
December 1 2013
Last Update
March 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of WI Comprehensive Cancer Center and UW Health Clinics
Madison, Wisconsin, United States, 53716